US FDA generics chief moves to new role
This article was originally published in Scrip
Executive Summary
Gary Buehler, who has been the head of the US Food and Drug Administration’s Office of Generic Drugs for nearly a decade, is moving to a new role within the agency. In his new position, Mr Buehler will play a key role in negotiations and activities relating to generic drug user fees.